相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B Cell Depletion Therapy Exacerbates Murine Primary Biliary Cirrhosis
Amy Dhirapong et al.
HEPATOLOGY (2011)
CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis
M. P. LEON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis
Ana Lleo et al.
HEPATOLOGY (2010)
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
Erika Irie et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
Thomas Doerner et al.
AUTOIMMUNITY REVIEWS (2009)
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Edith M. M. Kuiper et al.
GASTROENTEROLOGY (2009)
B-Cell Depletion with Anti-CD20 Ameliorates Autoimmune Cholangitis but Exacerbates Colitis in Transforming Growth Factor-β Receptor II Dominant Negative Mice
Yuki Moritoki et al.
HEPATOLOGY (2009)
Primary Biliary Cirrhosis
Keith D. Lindor et al.
HEPATOLOGY (2009)
CONNECTIVE TISSUE DISEASES The conundrum of B cell depletion in SLE
Inaki Sanz
NATURE REVIEWS RHEUMATOLOGY (2009)
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
David Saadoun et al.
BLOOD (2008)
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease
Kanji Wakabayashi et al.
HEPATOLOGY (2008)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2008)
Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
Ruediger Eming et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
M. Eric Gershwin et al.
HEPATOLOGY (2008)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
P. P. Sfikakis et al.
CLINICAL IMMUNOLOGY (2007)
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
Therese Vallerskog et al.
CLINICAL IMMUNOLOGY (2007)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory
Shinji Shimoda et al.
GASTROENTEROLOGY (2006)
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2006)
B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection
Frances E. Lund et al.
JOURNAL OF IMMUNOLOGY (2006)
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis
RY Lan et al.
HEPATOLOGY (2006)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
A Jacoby et al.
GUT (2005)
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid
G Treiber et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Medical progress: Primary biliary cirrhosis
MM Kaplan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives
YH Chuang et al.
JOURNAL OF AUTOIMMUNITY (2005)
Identification and characterization of circulating human transitional B cells
GP Sims et al.
BLOOD (2005)
Bacterial CpG induces hyper-IgM production in CD27+ memory B cells in primary biliary cirrhosis
K Kikuchi et al.
GASTROENTEROLOGY (2005)
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis
KA Keogh et al.
ARTHRITIS AND RHEUMATISM (2005)
Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis
S Matsumura et al.
HEPATOLOGY (2004)
Treatment of IgM antibody associated polyneuropathies using rituximab
A Pestronk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis
T Kamihira et al.
GASTROENTEROLOGY (2003)
Treatment of childhood autoimmune haemolytic anaemia with rituximab
P Quartier et al.
LANCET (2001)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
A critical role for B cells in the development of memory CD4 cells
PJ Linton et al.
JOURNAL OF IMMUNOLOGY (2000)
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
P Angulo et al.
HEPATOLOGY (2000)
分享论文
